Antibodies: At The Nexus of Antigens and Cancer Vaccines.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26116735.
- Also identified by DOI 10.1093/infdis/jiu638 and PMC identifier 4490205.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This review describes the development of monoclonal antibodies and the inception of their use in cancer therapy, their impact on defining cancer biomarkers, and their structural utility in new cancer vaccine development.
Medical subject headings
- Antibodies
- Cancer Vaccines
- Neoplasms